Need for High Permeability and Painless Transdermal Administration Boost Microneedle Drug Delivery Market
Nearly 16 billion injections are transdermally administered worldwide, annually. However, the traditional approach of transdermal delivery through hypodermic needles deters the application potential of this essential device due to the pain perception, risks involved with needle-stick injuries, and transport barrier limit of the outermost skin layer, stratum corneum.
Designed as a painless and minimally invasive system, microneedle arrays (MNAs) are the most sought-after resources to attain optimal systemic effects by transdermal delivery of drugs. With technological superiority to bypass the stratum corneum, it supersedes alternatives, viz. subcutaneous injections and other transdermal delivery systems such as nano and microparticles, or chemical enhancers.
The key objective of this technology is to achieve penetration smaller than holes by hypodermic needles to disrupt the stratum corneum. It thereby aims to create a larger transport pathway of micron size which is larger than molecular dimensions to allow large molecules to pass through, thereby increasing the permeability.
An Array of Benefits Push Adoption of Novel Microneedle Systems
Microneedle drug delivery system offers multiple benefits such as self-administration, better patient compliance, faster onset of action, and improved permeability and efficacy. Alongside improved therapeutic advantages, microneedles give highly accurate reproducible results with minimum inter-subject variability in bioavailability. As a painless drug delivery mechanism, microneedle systems help to tackle fear of needles, i.e., trypanophobia, thus driving adoption in mass immunisation programmes and in the pediatrics segment.
The rate of drug delivery can be controlled more effectively by this system as compared to that by other transdermal drug delivery methods. Faster healing at injection site than with a hypodermic needle is a peculiar benefit that it offers. Enhanced drug efficacy may result in good tolerability and dose reduction. Like any other technology, MNA also possesses some limitations. Possibility of allergy or skin irritation to sensitive skin or instances like breaking of microneedle tips may hinder optimal growth.
Diverse Application Base Makes Microneedles an Attractive R&D Space
In the past few decades, there has been high growth in demand for therapies (antibodies, antigens, proteins, and other biotechnological) wherein active substances are not adequately absorbed when administered orally. Also, newer technologies for encapsulation of these drugs in micro and nanoparticles have been developed. These molecules have become the most interesting candidates for microneedle drug delivery. The number of patents registered in recent years also shows a steady growth trail of MNA as a transdermal drug delivery system.
Transdermal administration is considered as a promising immunisation route and ovalbumin (OVA) is the most commonly used protein antigen for immunisation studies using MNA. Various therapies such as protein, insulin, vitamin, antibiotic, and natural compounds are also administered via microneedle drug delivery system.
At present, cosmeceuticals are probably one of the most tested ingredient groups in clinical trials, in combination with MNA. Recently, significant interest has also grown around the application of microneedle-based devices in the field of diagnostics. Microneedles have a promising potential to penetrate the wearable epidermal diagnostic devices segment due to their painless and noninvasive attributes. Microneedle-based transdermal drug delivery and the success of these minimally invasive devices would open up a wide range of therapeutic opportunities for oral, buccal, ocular, and rectal drug delivery.
Solid Microneedles Capture a Significant Market Share
On the basis of fabrication, microneedles are typically classified in four categories, viz. solid (coated and uncoated), dissolving, hydrogel, and hollow microneedles. Solid microneedle is a time-tested technology and marketed for longer duration. Solid microneedles are primarily made of metal and silicon materials. Polymers are slowly yet steadily catching up as a preferred material for solid microneedles. There is an upsurge in polymer-based microneedle publications (~68%) compared to that in other materials over the past five years.
Hollow and hydrogel microneedles remain the prominent segments, of which the former delivers higher API quantity compared to other microneedles. Moreover, the ease of manufacturing, low cost, and precise drug release control from the liquid penetration are some of the advantages of hollow microneedles. Nowadays, dissolving microneedles manufactured using biodegradable materials are catching attention in the market, as they enable eco-friendly API delivery without creating bio-contaminated and non-degradable waste.
Companies Focus on Collaborations and R&D Initiatives for Long-term Growth
NanoPass Technologies Ltd. recently announced to partner with globally leading vaccine and immunotherapy companies to share its proprietary MicronJet microneedle device to facilitate a safe, effective, and affordable COVID-19 vaccine development. Corium, Inc. is investigating MicroCor PTH (1-34) product candidate with Eli Lilly’s Forteo® (teriparatide [rDNA origin] injection), which is approved for the treatment of osteoporosis.
3M, Microdermics, Zosano Pharma Corporation (ZSAN), Nitto Denko Corporation, Becton, Dickinson and Company, Vaxxas Pty Ltd, Valeritas (Zealand Pharma A/S), Corium, Inc., TheraJect, Inc., LTS Lohmann Therapie-Systeme AG, Alza Corporation, and NanoPass Technologies Ltd. are some of the most prominent players actively participating in the global microneedle drug delivery market landscape.
Regional Classification of the Global Microneedle Drug Delivery Market is Listed Below:
North America
- U.S.
- Canada
Europe
- Germany
- France
- Spain
- U.K.
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East and Africa
- GCC
- South Africa
- Rest of Middle East & Africa
*Regions and countries are subject to change based on data availability.
Key Elements Included In The Study: Global Microneedle Drug Delivery Market
- Microneedle Drug Delivery Market by Product/Technology/Grade, Application/End-user, and Region
- Executive Summary (Opportunity Analysis and Key Trends)
- Historical Market Size and Estimates, Value, 2018 - 2022
- Market Value at Regional and Country Level, 2023 - 2030
- Market Dynamics and Economic Overview
- Market Size in Value, Growth Rates, and Forecast Figures, 2023 - 2030
- Competitive Intelligence with Financials, Key Developments, and Portfolio of Leading Companies
- Regional and Product/Grade/Application/End-user Price Trends Analysis
- Value Chain and Five Force’s Analysis
- Regional/Sub-region/Country Market Size and Trend Analysis
- Company Market Share Analysis and Key Player Profiles
Post Sale Support, Research Updates & Offerings
We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.
- The report will be prepared in a PPT format and will be delivered in a PDF format.
- Additionally, Market Estimation and Forecast numbers will be shared in Excel Workbook.
- If a report being sold was published over a year ago, we will offer a complimentary copy of the updated research report along with Market Estimation and Forecast numbers within 2-3 weeks’ time of the sale.
- If we update this research study within the next 2 quarters, post purchase of the report, we will offer a Complimentary copy of the updated Market Estimation and Forecast numbers in Excel Workbook.
- If there is a geopolitical conflict, pandemic, recession, and the like which can impact global economic scenario and business activity, which might entirely alter the market dynamics or future projections in the industry, we will create a Research Update upon your request at a nominal charge.
1. Executive Summary
1.1. Global Microneedle Drug Delivery Market Outlook, 2018 - 2030 (US$ Million)
1.2. Global Microneedle Drug Delivery Market Incremental Opportunity, 2018 - 2030 (US$ Million)
1.3. Key Industry Trends
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.1.1. Driver 1
2.2.1.2. Driver 2
2.2.2. Restraints
2.2.2.1. Restraint 1
2.2.2.2. Restraint 2
2.2.3. Opportunities
2.2.3.1. Opportunity 1
2.2.3.2. Opportunity 2
2.3. Regulatory Scenario
2.4. Technological Advancements
2.5. Microneedle Array Research Publications Trend Analysis (2000-2019)
2.6. Clinical Trials Analysis
2.7. Marketed microneedle-based transdermal products
2.8. List of patents by :
2.8.1. Microneedle array technologies
2.8.2. Fabrication of mold
2.8.3. Therapeutic drugs delivered
2.9. COVID-19 Impact Analysis
3. Global Microneedle Drug Delivery Outlook, 2018 - 2030
3.1. Global Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
3.1.1. Key Highlights
3.1.2. Global Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
3.1.2.1. Coated Microneedles
3.1.2.2. Dissolving Microneedles
3.1.2.3. Hollow Microneedles
3.1.2.4. Hydrogel Microneedles
3.1.2.5. Solid Microneedles
3.1.3. Global Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
3.1.4. Global Microneedle Drug Delivery Market Attractiveness Analysis, by Product, 2023 - 2030
3.2. Global Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
3.2.1. Key Highlights
3.2.2. Global Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
3.2.2.1. Bio-macromolecule Delivery
3.2.2.2. Combination Therapy
3.2.2.3. Diagnostics
3.2.2.4. Drug Delivery
3.2.2.5. Ocular Drug Delivery
3.2.2.6. Vaccine & Gene Delivery
3.2.3. Global Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
3.2.4. Global Microneedle Drug Delivery Market Attractiveness Analysis, by Application, 2023 - 2030
3.3. Global Microneedle Drug Delivery Market Outlook, By Region, 2018 - 2030
3.3.1. Key Highlights
3.3.2. Global Microneedle Drug Delivery Market Outlook, by Region, Value (US$ Million), 2018 - 2030
3.3.2.1. North America
3.3.2.2. Europe
3.3.2.3. Asia Pacific
3.3.2.4. Latin America
3.3.2.5. Middle East & Africa
3.3.3. Global Microneedle Drug Delivery Market Share and BPS Analysis, by Region, 2023 and 2030
3.3.4. Global Microneedle Drug Delivery Market Attractiveness Analysis, by Region, 2023 - 2030
4. North America Microneedle Drug Delivery Market Outlook, 2018 - 2030
4.1. North America Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
4.1.1. Key Highlights
4.1.2. North America Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
4.1.2.1. Coated Microneedles
4.1.2.2. Dissolving Microneedles
4.1.2.3. Hollow Microneedles
4.1.2.4. Hydrogel Microneedles
4.1.2.5. Solid Microneedles
4.1.3. North America Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
4.2. North America Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
4.2.1. Key Highlights
4.2.2. North America Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
4.2.2.1. Bio-macromolecule Delivery
4.2.2.2. Combination Therapy
4.2.2.3. Diagnostics
4.2.2.4. Drug Delivery
4.2.2.5. Ocular Drug Delivery
4.2.2.6. Vaccine & Gene Delivery
4.2.3. North America Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
4.3. North America Microneedle Drug Delivery Market Outlook, By Country, 2018 - 2030
4.3.1. Key Highlights
4.3.2. North America Microneedle Drug Delivery Market Outlook, by Country, Value (US$ Million), 2018 - 2030
4.3.2.1. U.S.
4.3.2.2. Canada
4.3.3. North America Microneedle Drug Delivery Market Share and BPS Analysis, by Country, 2023 and 2030
5. Europe Microneedle Drug Delivery Market Outlook, 2018 - 2030
5.1. Europe Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
5.1.1. Key Highlights
5.1.2. Europe Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
5.1.2.1. Coated Microneedles
5.1.2.2. Dissolving Microneedles
5.1.2.3. Hollow Microneedles
5.1.2.4. Hydrogel Microneedles
5.1.2.5. Solid Microneedles
5.1.3. Europe Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
5.2. Europe Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
5.2.1. Key Highlights
5.2.2. Europe Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
5.2.2.1. Bio-macromolecule Delivery
5.2.2.2. Combination Therapy
5.2.2.3. Diagnostics
5.2.2.4. Drug Delivery
5.2.2.5. Ocular Drug Delivery
5.2.2.6. Vaccine & Gene Delivery
5.2.3. Europe Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
5.3. Europe Microneedle Drug Delivery Market Outlook, By Country, 2018 - 2030
5.3.1. Key Highlights
5.3.2. Europe Microneedle Drug Delivery Market Outlook, by Country, Value (US$ Million), 2018 - 2030
5.3.2.1. Germany
5.3.2.2. France
5.3.2.3. U.K.
5.3.2.4. Italy
5.3.2.5. Spain
5.3.2.6. Russia
5.3.2.7. Rest of Europe
5.3.3. Europe Microneedle Drug Delivery Market Share and BPS Analysis, by Country, 2023 and 2030
6. Asia Pacific Microneedle Drug Delivery Market Outlook, 2018 - 2030
6.1. Asia Pacific Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
6.1.1. Key Highlights
6.1.2. Asia Pacific Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
6.1.2.1. Coated Microneedles
6.1.2.2. Dissolving Microneedles
6.1.2.3. Hollow Microneedles
6.1.2.4. Hydrogel Microneedles
6.1.2.5. Solid Microneedles
6.1.3. Asia Pacific Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
6.2. Asia Pacific Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
6.2.1. Key Highlights
6.2.2. Asia Pacific Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
6.2.2.1. Bio-macromolecule Delivery
6.2.2.2. Combination Therapy
6.2.2.3. Diagnostics
6.2.2.4. Drug Delivery
6.2.2.5. Ocular Drug Delivery
6.2.2.6. Vaccine & Gene Delivery
6.2.3. Asia Pacific Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
6.3. Asia Pacific Microneedle Drug Delivery Market Outlook, By Country, 2018 - 2030
6.3.1. Key Highlights
6.3.2. Asia Pacific Microneedle Drug Delivery Market Outlook, by Country, Value (US$ Million), 2018 - 2030
6.3.2.1. Japan
6.3.2.2. China
6.3.2.3. India
6.3.2.4. Australia & New Zealand
6.3.2.5. South Korea
6.3.2.6. Rest of Asia Pacific
6.3.3. Asia Pacific Microneedle Drug Delivery Market Share and BPS Analysis, by Country, 2023 and 2030
7. Latin America Microneedle Drug Delivery Market Outlook, 2018 - 2030
7.1. Latin America Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
7.1.1. Key Highlights
7.1.2. Latin America Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
7.1.2.1. Coated Microneedles
7.1.2.2. Dissolving Microneedles
7.1.2.3. Hollow Microneedles
7.1.2.4. Hydrogel Microneedles
7.1.2.5. Solid Microneedles
7.1.3. Latin America Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
7.2. Latin America Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
7.2.1. Key Highlights
7.2.2. Latin America Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
7.2.2.1. Bio-macromolecule Delivery
7.2.2.2. Combination Therapy
7.2.2.3. Diagnostics
7.2.2.4. Drug Delivery
7.2.2.5. Ocular Drug Delivery
7.2.2.6. Vaccine & Gene Delivery
7.2.3. Latin America Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
7.3. Latin America Microneedle Drug Delivery Market Outlook, By Country, 2018 - 2030
7.3.1. Key Highlights
7.3.2. Latin America Microneedle Drug Delivery Market Outlook, by Country, Value (US$ Million), 2018 - 2030
7.3.2.1. Brazil
7.3.2.2. Mexico
7.3.2.3. Argentina
7.3.2.4. Rest of Latin America
7.3.3. Latin America Microneedle Drug Delivery Market Share and BPS Analysis, by Country, 2023 and 2030
8. Middle East & Africa Microneedle Drug Delivery Market Outlook, 2018 - 2030
8.1. Middle East & Africa Microneedle Drug Delivery Market Outlook, By Product, 2018 - 2030
8.1.1. Key Highlights
8.1.2. Middle East & Africa Microneedle Drug Delivery Market Outlook, by Product, Value (US$ Million), 2018 - 2030
8.1.2.1. Coated Microneedles
8.1.2.2. Dissolving Microneedles
8.1.2.3. Hollow Microneedles
8.1.2.4. Hydrogel Microneedles
8.1.2.5. Solid Microneedles
8.1.3. Middle East & Africa Microneedle Drug Delivery Market Share and BPS Analysis, by Product, 2023 and 2030
8.2. Middle East & Africa Microneedle Drug Delivery Market Outlook, By Application, 2018 - 2030
8.2.1. Key Highlights
8.2.2. Middle East & Africa Microneedle Drug Delivery Market Outlook, by Application, Value (US$ Million), 2018 - 2030
8.2.2.1. Bio-macromolecule Delivery
8.2.2.2. Combination Therapy
8.2.2.3. Diagnostics
8.2.2.4. Drug Delivery
8.2.2.5. Ocular Drug Delivery
8.2.2.6. Vaccine & Gene Delivery
8.2.3. Middle East & Africa Microneedle Drug Delivery Market Share and BPS Analysis, by Application, 2023 and 2030
8.3. Middle East & Africa Microneedle Drug Delivery Market Outlook, By Country, 2018 - 2030
8.3.1. Key Highlights
8.3.2. Middle East & Africa Microneedle Drug Delivery Market Outlook, by Country, Value (US$ Million), 2018 - 2030
8.3.2.1. Saudi Arabia
8.3.2.2. UAE
8.3.2.3. Israel
8.3.2.4. South Africa
8.3.2.5. Rest of Middle East & Africa
8.3.3. Middle East & Africa Microneedle Drug Delivery Market Share and BPS Analysis, by Country, 2023 and 2030
9. Competitive Landscape
9.1. Market Share Analysis, 2022
9.2. Company Profiles
9.2.1. 3M Corp.
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product Pipeline
9.2.1.4. Recent Developments
*Above details will include, but not be limited to below list of companies based on availability
9.2.2. Becton, Dickinson and Company
9.2.3. Corium International Inc.
9.2.4. CosMED Pharmaceutical Co. Ltd.
9.2.5. Debiotech
9.2.6. Derma spark
9.2.7. NanoPass Inc.
9.2.8. Sanofi Pasteur
9.2.9. TheraJect Inc.
9.2.10. Valeritas Inc.
9.2.11. Zosano Pharma Inc.
10. Appendix
10.2. Research Methodology
10.3. Report Specific Research Approach
10.4. Acronyms and Abbreviations
Download Sample Report
Member
Quality assured
